Nuclear Magnetic Resonance Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells

BACKGROUND: Malignant gliomas are rapidly growing tumours that extensively invade the brain and have bad prognosis. Our study was performed to assess the metabolic effects of bevacizumab on the glioma cells carrying the IDH1 mutation, a mutation, associated with better prognosis and treatment outcom...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Radiol Oncol
Hoofdauteurs: Mesti, Tanja, Bouchemal, Nadia, Banissi, Claire, Triba, Mohamed N., Marbeuf-Gueye, Carole, Cemazar, Maja, Moyec, Laurence Le, Carpentier, Antoine F., Savarin, Philippe, Ocvirk, Janja
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Sciendo 2018
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6287186/
https://ncbi.nlm.nih.gov/pubmed/30511933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2018-0046
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items